On #WorldCancerDay, we look at the political and regulatory challenges to U.S.-China collaboration and how to expedite the harmonization of cancer clinical trials in a new paper by @patbeyrer. Read below👇

Dr. Bob Li reflects on how the U.S. and China can work together to accelerate the development of cancer cures. On #WorldCancerDay, we are committed to international cooperation in the fight against cancer: https://t.co/xQD07hoylQ

Pleased to publish a new @AsiaSociety report on #WorldCancerDay. Drawing on the work of scientists, policymakers, and more, this report identifies the challenges and opportunities within US-China scientific ties to change cancer care as we know it. 🧵 https://t.co/EWtf8VyVvG

On #WorldCancerDay, we are committed to driving progress to decrease the cancer burden worldwide by raising public awareness on the benefits of international collaboration to accelerate the development of cancer cures. Learn more: https://t.co/WCCuvbVzMt

#Cancer claims 10 million lives annually, straining families & #healthcare systems worldwide. Our latest report in the Advancing Global Health Equity for the #Cure4Cancer series with @Cure4C examines how international collaboration and regulatory harmonization in clinical

Cancer claims 10M lives annually, straining families & #healthcare systems worldwide. The latest report in the Advancing Global Health Equity for the #Cure4Cancer series by @asiapolicy and @Cure4C examines how international collaboration and regulatory harmonization in clinical

Could the Chinese biotech sector be the next risky frontier between the United States and China? Read this new and timely ASPI and @Cure4C paper by @patbeyrer on U.S.-China biotech competition.

Watch our full interview with Dr. Daly:

Read the paper:

Clinical trial remote monitoring and data collection could improve participation by removing financial and logistic burdens. @BobbyDalyMD & Dr. Bob Li published a study in @JAMANetworkOpen that evaluated remote technologies and identified areas for growth. @BBGNewEconomy

Clinical trial remote monitoring and data collection could improve participation by removing financial and logistic burdens. @BobbyDalyMD & Dr. Bob Li published a study in @JAMANetworkOpen that evaluated remote technologies and identified areas for growth.

On #WorldCancerDay, we are committed to a #GlobalCancerMoonshot, driving progress to decrease the cancer burden worldwide by raising public awareness to accelerate the development of cancer cures. @AsiaPolicy Learn more:

Focusing on equity and access, Cure4Cancer is working to improve outcomes for patients nationwide by bringing together multi-regional stakeholders to accelerate the development of cancer cures. #GlobalCancerMoonshot #WorldCancerDay @AsiaPolicy https://t.co/ToAmB8ClCt

Join the movement and visit us [6/6]:

@US_FDA Dr. Richard Pazdur joined us for an interview on the need to focus on multi-regional clinical trials as the critical path to lessen the cancer burden worldwide. [5/6]

@MrKRudd discussed U.S.-Australia collaboration in the fight against cancer and the importance of our shared mission to foster international collaboration to accelerate cancer cures. [4/6]

Amb. Caroline Kennedy delivered remarks on the #CancerMoonshot and the movement to end cancer as we know it. [3/6]

@catgyoung of #WhiteHouseCancerMoonshot delivered an address on how we can come together to decrease the cancer burden across the globe. [2/6]

Ahead of #WorldCancerDay, we are delighted to highlight our commitment to a #GlobalCancerMoonshot. Our Cure4Cancer conference highlighted the importance of advancing global health equity and harmonization. [1/6]

@MrKRudd discussed U.S.-Australia collaboration in the fight against cancer and the importance of our shared mission to foster international collaboration to accelerate cancer cures.